Trademark Search in Canada

ALBUMEDIX

View On IC.GC.CA

REGISTERED

on 25 Nov 2019

Last Applicant/ Owned by

ALBUMEDIX LTD

HQ, Mabel StreetNottinghamNG2 3ED

Serial Number

1795875 filed on 15^th Aug 2016

Registration Number

TMA1064210 registered on 25^th Nov 2019

Registration expiry Date

25^th Nov 2029

Correspondent Address

BENNETT JONES LLP

SUITE 3400, ONE FIRST CANADIAN PLACEP.O. BOX 130TORONTO

ONTARIO

M5X1A4

ALBUMEDIX

Trademark usage description

chemicals, namely, chemical additives, chemical catalysts, chemical agents and chemical preservatives for the manufacture of pharmaceutical products; Read More

Classification Information

Class [001]
Chemicals, namely, chemical additives, chemical catalysts, chemical agents and chemical preservatives for the manufacture of pharmaceutical products; albumin, namely human albumin, recombinant human albumin and human serum albumin used in industry for the preparation of pharmaceutical compositions, reagents, namely reagents for medical purposes, reagents for medical research, reagents for research purposes, and diagnostic reagents.

Classification kind code

Class [005]
Pharmaceutical compositions and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; reagents for pharmaceutical and medical use, namely ingredients used in the manufacture, formulation, stabilization, solubilization and preservation of therapeutic preparations and vaccines; reagents used to stabilize ingredients used in diagnostic kits; biocompatible agents used to coat medical devices; medical diagnostic reagents; additives for use in the manufacture of pharmaceuticals and vaccines; diagnostic reagents for medical use, namely diagnostic reagents for medical diagnostic use, diagnostic reagents for medical laboratory use, diagnostic reagents for medical-scientific research use, diagnostic biomarker reagents for medical use; proteins and albumin for pharmaceutical and medical purposes, namely human and synthetic proteins, therapeutic proteins, recombinant albumin, human serum albumin and recombinant human albumin for use as cellular absorption, enzyme stabilizers and anti-coagulant agents in the testing and manufacture of pharmaceuticals and for medical laboratory use; recombinant albumin for pharmaceutical and medical purposes, namely recombinant human albumin sold as an integral component of a vaccine and pharmaceuticals for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic contrast agents for medical imaging.

Classification kind code

Class [042]
Pharmaceutical research and pharmaceutical development services relating to pharmaceutical products; consultancy and expert assistance in the development of medicines and pharmaceutical products as well as analysis and development services, namely chemical analysis, biochemical analysis, product development, pharmaceutical product development, chemical products development.

Classification kind code

Mark Details

Serial Number

1795875

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 20^th Feb 2019	Advertised
Submitted for opposition 26 on 31^st Jan 2019	Approved
Submitted for opposition 27 on 11^th Dec 2018	Approval Notice Sent
Submitted for opposition 80 on 13^th Aug 2018	Change of Title Registered
Submitted for opposition 12 on 25^th Apr 2018	Extension of Time
Submitted for opposition 22 on 25^th Jul 2017	Search Recorded
Submitted for opposition 20 on 25^th Jul 2017	Examiner's First Report
Submitted for opposition 31 on 17^th Aug 2016	Formalized
Submitted for opposition 1 on 16^th Aug 2016	Created
Submitted for opposition 30 on 15^th Aug 2016	Filed